ESC Premium Access

Low-dose rivaroxaban after left atrial appendage closure: The randomized ADRIFT study

Congress Session

About the speaker

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

4 more presentations in this session

Immediate versus Delayed Stenting After Primary Percutaneous Reperfusion in ST-Elevation Myocardial Infarction: The PRIMACY Bayesian Randomized Controlled Trial

Speaker: Doctor M. Jolicoeur (Montreal, CA)

Thumbnail

Percutaneous left atrial appendage closure versus novel anticoagulation agents in high-risk atrial fibrillation patients (PRAGUE-17 study)

Speaker: Doctor P. Osmancik (Prague, CZ)

Thumbnail

Ultrathin-strut biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in acute myocardial infarction: a randomized controlled trial

Speaker: Doctor J. Iglesias (Geneva, CH)

Thumbnail

Randomized, Multicenter Comparison of Intensified versus Standard Loading Strategies with P2Y12-Receptor-Inhibitors in Patients Undergoing Elective PCI

Speaker: Professor J. Mehilli (Landshut, DE)

Thumbnail

Access the full session

Late Breaking Science in Intervention

Speakers: Professor G. Montalescot, Doctor M. Jolicoeur, Doctor P. Osmancik, Doctor J. Iglesias, Professor J. Mehilli
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk